Shanghai Pharmaceuticals Holding Co Ltd
601607
Company Profile
Business description
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2023, medical distribution is the largest segment, accounting for 89.8% of total revenue. It also has coverage of 31 provinces and cities nationwide.
Contact
No. 200 Taicang Road
Shanghai Pharmaceutical Building
Shanghai200020
CHNT: +86 2163730908
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2025
Employees
49,234
Stocks News & Analysis
stocks
The fight for Insignia continues
Numerous acquisition proposals vindicate Insignia's improved earnings momentum.
stocks
Trouble continues as Star Entertainment burns through cash
More pain in the horizon as the company struggles to stay afloat.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,627.80 | 52.70 | -0.61% |
| CAC 40 | 7,837.40 | 66.45 | 0.86% |
| DAX 40 | 21,254.27 | 212.27 | 1.01% |
| Dow JONES (US) | 44,156.73 | 130.92 | 0.30% |
| FTSE 100 | 8,545.13 | 3.16 | -0.04% |
| HKSE | 19,895.68 | 116.91 | 0.59% |
| NASDAQ | 20,009.34 | 252.56 | 1.28% |
| Nikkei 225 | 39,830.11 | 183.86 | 0.46% |
| NZX 50 Index | 13,060.53 | 23.39 | 0.18% |
| S&P 500 | 6,086.37 | 37.13 | 0.61% |
| S&P/ASX 200 | 8,377.30 | 52.50 | -0.62% |
| SSE Composite Index | 3,260.37 | 46.75 | 1.45% |